COLLAGENASE 2/MATRIX METALLOPROTEINASE 8 IN CRITICALLY ILL PATIENTS WITH SECONDARY PERITONITIS

    loading  Checking for direct PDF access through Ovid

Abstract

ABSTRACT

Secondary peritonitis is an important indication for surgical intensive care admissions, and it is associated with high morbidity and mortality. Collagenase 2/matrix metalloproteinase (MMP) 8 is a tissue matrix-degrading enzyme that is released from leukocytes upon inflammatory stimuli and may thus contribute to peritonitis-associated organ damage. We studied the levels and activity of MMP-8 in the peritoneal fluid of 15 critically ill patients with secondary peritonitis. The MMP-8 levels were measured from the patients' peritoneal fluid, serum, and urine, and from the serum and urine of 10 healthy controls by immunofluorometric assay. Median MMP-8 level in peritoneal fluid supernatant was 1,317 μg/L (interquartile range [IQR]) (1,254-1,359 μg/L) being significantly higher than in the sera of the patients (P = 0.008). Molecular forms and isoform distribution of MMP-8, MMP-1, and MMP-13 in peritoneal fluid, assessed by Western immunoblotting, revealed that the neutrophil-type MMP-8 was the major collagenase species in peritoneal fluid, and it was partially in an activated form. Catalytically competent, active MMP-8 produced the characteristic cleavage products from intact human type I collagen. The serum levels of MMP-8 were higher in the patients, 49 μg/L (IQR, 23-214 μg/L), than in the controls, 11 μg/L (IQR, 8-24 μg/L) (P < 0.01). The MMP-8 levels in the urine were higher in the patients, 0.27 μg/L (IQR, 0.04-1.89 μg/L), than in the controls, 0.03 μg/L (IQR, 0.0-0.05 μg/L) (P = 0.013). Our data demonstrate for the first time that MMP-8 levels are remarkably elevated and in an active and catalytically competent form in the peritoneal fluid samples of patients with secondary peritonitis.

Related Topics

    loading  Loading Related Articles